5 results
RIPE Therapy - Drug Regimens for Microbiologically Confirmed Pulmonary Tuberculosis - IDSA Guidelines

#Tuberculosis #ActiveTB #RIPE #Therapy
RIPE Therapy - Drug ... Guidelines # ... #medications #pharmacology ... #IDSA #Guidelines ... #Treatment
IDSA - Clinical Strategy to Build an Individualized Treatment Regimen for Multi-Drug Resistant Tuberculosis (MDR-TB)
 •
IDSA - Clinical ... Regimen for Multi-Drug ... clarithromycin #MultiDrugResistant ... #pharmacology # ... dosing #idsa #drugs
Daliresp (Roflumilast) 
Indication: Reduce risk of COPD exacerbations 
Drug Class: Selective Phosphodiesterase-4 (PDE4) Inhibitor 
GOLD 2019
exacerbations Drug ... while adherent to regimen ... recommendations for the treatment ... therapy inhalation regimen ... #Indications #Pharmacology
IDSA Summary of recommendations on drugs for use in a treatment regimen for patients with
multidrug-resistant tuberculosis,
IDSA Summary of ... recommendations on drugs ... regimen for patients ... Delamanid #MultiDrugResistant ... antimicrobials #pharmacology
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
IDSA Recommendations ... RAL-based ART regimen ... Adolescent ARV Guidelines ... Tuberculosis #TB #IDSA ... infections #HIVAIDS #pharmacology